Which manufacturer does Carfilzomib come from?

Carfilzomib (Carfilzomib) is developed and produced by Amgen. Amgen is a multinational pharmaceutical company headquartered in California, USA. Founded in 1980, it focuses on research and production in the fields of biotechnology and biopharmaceuticals. Carfilzomib was originally developed by Proteolix (predecessor) and later acquired by Amgen in 2015. After years of research and clinical trials, this drug was finally approved by drug regulatory agencies in various countries, including the U.S. Food and Drug Administration (FDA). The development and production of carfilzomib provides patients with better treatment options, improves their quality of life, and extends their survival.